Very cool and as always appreciated, thanks. As an investor love the quote below. As the Flaskworks device provides flexibility in the art of manufacturing to “optimize” the end product.
In addition to the features described above, other features will be apparent to those of skill in the art, as the disclosed systems and methods provide numerous opportunities for process optimization in immunotherapeutic product manufacturing.
Thx pgsd, great to see the thorough mfg process protection since DCVax therapy is not an easily protected compound. And these newer patents will have valuable runways. If we are not getting directly informed about the steps NWBO is taking it is great to know they are taking the right steps.